Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$66.81 - $80.83 $2.36 Million - $2.85 Million
-35,300 Reduced 53.48%
30,700 $2.39 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $1.45 Million - $1.66 Million
-23,800 Reduced 26.5%
66,000 $4.47 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $1.1 Million - $1.23 Million
17,700 Added 24.55%
89,800 $6.05 Million
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $4.68 Million - $5.17 Million
72,100 New
72,100 $4.88 Million
Q1 2023

May 15, 2023

SELL
$63.15 - $71.6 $315,750 - $358,000
-5,000 Reduced 34.01%
9,700 $673,000
Q4 2022

Feb 14, 2023

BUY
$54.21 - $70.44 $796,887 - $1.04 Million
14,700 New
14,700 $996,000
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $231,114 - $277,446
3,900 New
3,900 $258,000
Q4 2021

Feb 14, 2022

SELL
$54.02 - $63.83 $2.86 Million - $3.38 Million
-53,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$55.56 - $60.79 $2.56 Million - $2.8 Million
46,100 Added 668.12%
53,000 $3.18 Million
Q2 2021

Aug 16, 2021

BUY
$48.42 - $60.18 $334,098 - $415,242
6,900 New
6,900 $413,000
Q1 2021

May 17, 2021

SELL
$47.16 - $54.44 $561,204 - $647,836
-11,900 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $329,936 - $394,536
6,800 Added 133.33%
11,900 $595,000
Q1 2019

May 15, 2019

SELL
$35.49 - $43.02 $582,036 - $705,528
-16,400 Reduced 76.28%
5,100 $206,000
Q4 2018

Feb 14, 2019

BUY
$36.86 - $41.49 $55,290 - $62,235
1,500 Added 7.5%
21,500 $817,000
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $1.49 Million - $1.71 Million
-43,000 Reduced 68.25%
20,000 $791,000
Q2 2018

Aug 14, 2018

SELL
$34.55 - $37.05 $2.05 Million - $2.2 Million
-59,400 Reduced 48.53%
63,000 $2.21 Million
Q1 2018

May 15, 2018

BUY
$32.97 - $36.63 $4.04 Million - $4.48 Million
122,400 New
122,400 $4.28 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.